Safety and Feasibility of Lung Resection after Immunotherapy for Metastatic or Unresectable Tumors

BACKGROUND: Surgeons are increasingly asked to operate on patients with residual disease after immunotherapy. The safety and utility of lung resection in this setting are unknown. METHODS: We performed a retrospective review of patients who underwent lung resection within 6 months of treatment with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Thorac Surg
Hauptverfasser: Bott, Matthew J., Cools-Lartigue, Jonathan, Tan, Kay See, Dycoco, Joseph, Bains, Manjit S., Downey, Robert J., Huang, James, Isbell, James M., Molena, Daniela, Park, Bernard J., Rusch, Valerie W., Sihag, Smita, Jones, David R., Adusumilli, Prasad S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357770/
https://ncbi.nlm.nih.gov/pubmed/29550207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2018.02.030
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge